Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Eli Lilly acquires AtaiBeckley for mental health pipeline

PUBLIC · LLYSep 12, 2026about 5 hours ago

Acquiring Company

Eli Lilly and

Acquired Company

AtaiBeckley

IndianapolisUnited StatesManufacturingBiotechnologyHealth CareMedicalPharmaceuticalBiotechnologyHealth CareTherapeutics

Description

Eli Lilly and Co. has completed the acquisition of AtaiBeckley, enhancing its investigational mental health pipeline. The deal includes a cash component and contingent value rights based on future milestones. AtaiBeckley will now operate as a subsidiary, contributing to Lilly's neuroscience initiatives. This acquisition aims to improve options for treatment-resistant depression.

Company Information

Company

Eli Lilly and

Location

Indianapolis, Indiana, United States

About

Eli Lilly and Co. is a leading global pharmaceutical company that develops and delivers innovative pharmaceutical drugs.

Don't miss Eli Lilly and's next move

Get an email the moment Eli Lilly and makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Juan
Likely contact at this company
••••••••@••••••••

See Juan's verified email →

Miranda
Likely contact at this company
••••••••@••••••••

See Miranda's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Eli Lilly and's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired AtaiBeckley?

AtaiBeckley was acquired by Eli Lilly and, based in Indianapolis. The deal was reported on September 12, 2026. Eli Lilly and Co. is a leading global pharmaceutical company that develops and delivers innovative pharmaceutical drugs. Eli Lilly and is publicly traded (LLY) and operates in Manufacturing.

When did Eli Lilly and acquire AtaiBeckley?

Eli Lilly and's acquisition of AtaiBeckley was reported on September 12, 2026. Eli Lilly and Co. has completed the acquisition of AtaiBeckley, enhancing its investigational mental health pipeline. The deal includes a cash component and contingent value rights based on future milestones. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does AtaiBeckley do?

AtaiBeckley Inc. is a biotechnology company based in Delaware, primarily focused on the development of novel therapeutics for mental health disorders. It is publicly traded (ATAI), operating in Biotechnology, and is based in United States.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.